Evaluation of heat-treating heartworm-positive canine serum samples during treatment with Advantage Multi® for Dogs and doxycycline
Abstract Background The use of heat-treatment in canine and feline serum has been hypothesized to break the formation of antigen-antibody complexes, thereby freeing the heartworm antigen allowing for detection by commercially available heartworm antigen kits. While studies have analyzed the effect o...
Main Authors: | Molly D. Savadelis, Jennifer L. Roveto, Cameon M. Ohmes, Joe A. Hostetler, Terry L. Settje, Michael T. Dzimianski, Andrew R. Moorhead |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-02-01
|
Series: | Parasites & Vectors |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13071-018-2685-z |
Similar Items
-
Assessment of parasitological findings in heartworm-infected beagles treated with Advantage Multi® for dogs (10% imidacloprid + 2.5% moxidectin) and doxycycline
by: Molly D. Savadelis, et al.
Published: (2017-05-01) -
Efficacy of semi-annual therapy of an extended-release injectable moxidectin suspension and oral doxycycline in Dirofilaria immitis naturally infected dogs
by: Bruno Alberigi, et al.
Published: (2020-10-01) -
Preventive efficacy of oral moxidectin at various doses and dosage regimens against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs
by: Tom L. McTier, et al.
Published: (2019-09-01) -
Laboratory and field studies to investigate the efficacy of a novel, orally administered combination product containing moxidectin, sarolaner and pyrantel for the prevention of heartworm disease (Dirofilaria immitis) in dogs
by: Kristina Kryda, et al.
Published: (2019-09-01) -
ProHeart® 12, a moxidectin extended-release injectable formulation for prevention of heartworm (Dirofilaria immitis) disease in dogs in the USA for 12 months
by: Tom L. McTier, et al.
Published: (2019-07-01)